KURA
Kura Oncology, Inc. · Healthcare · Market cap $634.9M
Insiders bought $762K net in the last 90 days ·6 sellers, 1 buyer· 14 of 19 sales under Rule 10b5-1 plans· latest Form 4 filed Nov 19, 2026
Insider Buying
$3.9M
reported purchases (SEC code P)
Insider Selling
$4.0M
reported sales (SEC code S)
Unique Insiders
8
in the rolling window
Latest filing
Nov 19, 2026
Powl Brian T.
Kura Oncology, Inc. (KURA) has 38 SEC Form 4 filings (60 transaction rows) in the rolling window, disclosed by 8 distinct insiders. Most recent filing: Nov 19, 2026.
Inside the rolling window, 8 insiders at Kura Oncology, Inc. reported 4 open-market purchases totaling $3.9M and 33 open-market sales totaling $4.0M. The most active filer is Chief Commercial Officer Powl Brian T. with 9 filings. Insiders have net bought $642K over the trailing 6 months. The largest single insider purchase in this window was $1.2M by President and CEO WILSON TROY EDWARD on Aug 24, 2026. The most recent open-market filing is a sale of 448 shares by Chief Commercial Officer Powl Brian T., dated Nov 19, 2026, worth $3K.
- Industry:Biotechnology
- CEO:Troy Wilson
- Employees:260
- HQ:San Diego, CA, US
- IPO:2015-09-16
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chief Commercial Officer | Sale | 448 | $3K | Nov 19 | -6.0% | SEC ↗ | |
| Chief Medical Officer | Sale | 19,009 | $141K | Nov 18 | -5.9% | SEC ↗ | |
| Chief Medical Officer | Sale | 22,241 | $166K | Nov 18 | -5.9% | SEC ↗ | |
| Chief Operating Officer | Sale | 7,042 | $52K | Nov 18 | -5.9% | SEC ↗ | |
| Chief Operating Officer | Sale | 3,668 | $27K | Nov 18 | -5.9% | SEC ↗ | |
| Chief Legal Officer | Sale | 8,601 | $64K | Nov 18 | -5.9% | SEC ↗ | |
| Chief Commercial Officer | Sale | 9,196 | $68K | Nov 18 | -5.9% | SEC ↗ | |
| Chief Commercial Officer | Sale | 15,254 | $114K | Nov 18 | -5.9% | SEC ↗ | |
| SVP, Finance & Accounting | Sale | 4,697 | $35K | Nov 18 | -5.9% | SEC ↗ | |
| President and CEO | Purchase | 98,881 | $754K | Nov 17 | -7.7% | SEC ↗ | |
| President and CEO | Purchase | 101,119 | $750K | Nov 17 | — | SEC ↗ | |
| Chief Legal Officer | Sale | 8,442 | $89K | Sep 29 | — | SEC ↗ | |
FORD KATHLEENFirst in 4 months | Chief Operating Officer | Sale | 6,906 | $72K | Sep 29 | — | SEC ↗ |
FORD KATHLEENFirst in 4 months | Chief Operating Officer | Sale | 3,668 | $39K | Sep 29 | — | SEC ↗ |
Leoni MollieFirst in 3 months | Chief Medical Officer | Sale | 12,448 | $131K | Sep 29 | — | SEC ↗ |
Leoni MollieFirst in 3 months | Chief Medical Officer | Sale | 28,802 | $310K | Sep 29 | — | SEC ↗ |
DOYLE THOMAS JAMESFirst in 8 months | SVP, Finance & Accounting | Sale | 4,607 | $48K | Sep 29 | — | SEC ↗ |
| Chief Commercial Officer | Sale | 17,020 | $179K | Sep 29 | — | SEC ↗ | |
| Chief Commercial Officer | Sale | 15,430 | $166K | Sep 29 | — | SEC ↗ | |
Burrows FrancisFirst in 8 months | Chief Scientific Officer | Sale | 20,726 | $225K | Sep 25 | — | SEC ↗ |
Powl Brian T.First in 3 months | Chief Commercial Officer | Sale | 4,345 | $52K | Aug 24 | — | SEC ↗ |
| President and CEO | Purchase | 100,000 | $1.2M | Aug 24 | — | SEC ↗ | |
Bair Teresa BrophyFirst in 3 months | Chief Legal Officer | Sale | 31,487 | $398K | Aug 21 | — | SEC ↗ |
| President and CEO | Purchase | 100,000 | $1.1M | Aug 17 | — | SEC ↗ | |
Leoni MollieFirst in 5 months | Chief Medical Officer | Sale | 84,929 | $834K | Jun 22 | — | SEC ↗ |
Congress trading KURA 1 all-time
- RRep. Chris JacobsPurchase$1,001 - $15,0002022-12-12
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does KURA have?
Kura Oncology, Inc. (KURA) has 38 SEC Form 4 filings (60 transaction rows) in the rolling 365-day window, disclosed by 8 distinct insiders. Most recent filing: Nov 19, 2026.
When was the most recent SEC Form 4 filing for KURA?
The most recent Form 4 filing for KURA on Tracefour is dated Nov 19, 2026.
Who is the most active insider at KURA?
The most active SEC Form 4 filer at KURA in the rolling window is Chief Commercial Officer Powl Brian T., with 9 filings.
What is the net insider flow at KURA over the last 6 months?
Over the trailing 180 days, insiders at KURA have net bought $642K based on SEC Form 4 disclosures.
What was the largest insider purchase at KURA?
The largest single insider open-market purchase at KURA in the rolling window was $1.2M by President and CEO WILSON TROY EDWARD on 2026-08-24.
What is the total insider buy and sell value at KURA in the current window?
Inside the rolling window, insiders at KURA bought $3.9M and sold $4.0M based on SEC Form 4 filings.
Can I get alerts for KURA insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Kura Oncology, Inc. (KURA). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Kura Oncology, Inc. is in the Healthcare sector.